Inhibition of CSPG-PTPσ Activates Autophagy Flux and Lysosome Fusion, Aids Axon and Synaptic Reorganization in Spinal

Hongyu Wang1,2,3,4, Naibo Feng5,6, Chungeng Liu5,6

  • 1The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, 518055, China. wanghongyu790039663@126.com.

PubMed

Insights

Intracellular sigma peptide (ISP) activates autophagy and promotes synaptic reorganization after spinal cord injury (SCI). This treatment improves motor neuron survival and functional recovery, highlighting a new therapeutic avenue for SCI.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Regenerative Medicine

Background:

  • Chondroitin sulfate proteoglycans (CSPGs) and their receptor protein tyrosine phosphatase σ (PTPσ) are implicated in spinal cord injury (SCI) pathology.
  • Autophagy inhibition can induce CSPGs in astrocytes, but CSPG's influence on autophagy and its role in SCI remain unclear.

Purpose of the Study:

  • To investigate the effects of intracellular sigma peptide (ISP), which targets PTPσ, on autophagy and synaptic reorganization in the context of SCI.
  • To elucidate the therapeutic potential of ISP in promoting recovery after spinal cord injury.

Main Methods:

  • Utilized western blotting to assess autophagy markers (LC3B-II/I, p62) and autophagosome-lysosome fusion proteins (STX17, LAMP2).
  • Quantified pre- and post-synaptic markers (SYN, PSD-95, VGLUT1), axon markers (neurofilament, GAP-43), and motor neuron survival.
  • Evaluated neurobehavioral recovery in an SCI model.

Main Results:

  • ISP treatment activated autophagy flux by increasing LC3B-II/I and decreasing p62.
  • ISP restored autophagosome-lysosome fusion, evidenced by increased STX17 and LAMP2 levels.
  • ISP enhanced synaptic reorganization, promoted axon growth, preserved motor neurons, and improved neurobehavioral outcomes in SCI models.

Conclusions:

  • ISP targeting PTPσ activates autophagy flux, facilitates synaptic reorganization, and promotes functional recovery after SCI.
  • ISP demonstrates therapeutic potential for mitigating SCI pathology and enhancing recovery by influencing CSPG-PTPσ signaling and autophagy.

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
760
Postsynaptic Potential (PSP)01:32

Postsynaptic Potential (PSP)

Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
2.5K
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
2.8K